Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance.

By N. Schwenzer, F. Springer, C. Schraml, N. Stefan, J. Machann, F. Schick. Journal of Hepatology, 2009

754 citations recorded by the source corpus.

Subfields: Epidemiology, Hepatology, Molecular Biology

View Paper: https://www.semanticscholar.org/paper/70b7b1217a26230036a474a6138010c99be3b97b

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Epidemiology

1. Vincent Wai-Sun Wong
2. Asociacion Latinoamericana para el Estudio del Higado

In Hepatology

1. Asociacion Latinoamericana para el Estudio del Higado

In Molecular Biology

1. Manoj Kumar

Citations in the corpus

• Non-alcoholic fatty liver disease (NAFLD): a review of pathophysiology, clinical management and effects of weight loss (2022, background): “Imaging in NAFLD In liver diseases such as NAFLD and NASH, various imaging modalities can be used to substantiate the diagnosis, however none of them are routinely used for differentiating between (histological) subtypes of NAFLD or NASH [33].”
• Controlled attenuation parameter (CAP): a novel VCTE™ guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes. (2010, methodology): “CT scans are ionizing and therefore cannot be used for repeated liver evaluations (Schwenzer et al. 2009).”
• Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis. (2017, background): “[55] Schwenzer NF, Springer F, Schraml C, Stefan N, Machann J, Schick F.”